Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 4881 Yonge Street, Suite 300 Toronto ON M2N5X3 |
Tel: | N/A |
Website: | https://healwell.ai |
IR: | See website |
Key People | ||
Alex Dobranowski Chief Executive Officer, Director, Founder | G. Scott Nirenberski Chief Financial Officer, Corporate Secretary | Madeline Walker President - Corporate Health Solutions | Don Watts President - Khure Health |
Business Overview |
HEALWELL AI Inc. is a healthcare technology company focused on artificial intelligence (AI) and data science for preventative care. The Company is engaged in developing and acquiring technology and clinical sciences capabilities. Its clinical information sources consist of clinician and electronic medical records (EMR) access; clinical research and trials; lab and diagnostic info, and semi-structured data. It offers a range of clinical insights with life sciences companies, precision medicine companies, pharmaceutical companies, and medical device companies. It also focuses on identifying eligible patients for approved medications and interventions through its AI system, DARWEN. It offers Intrahealth an advanced software-as-a-service based HER management platform for small and medium enterprise healthcare organizations across Canada, Australia, and New Zealand. The platform meets the demands of a clients from a single doctor's office to a multi-thousand user health institution. |
Financial Overview |
For the three months ended 31 March 2024, Healwell Al Inc revenues increased from C$2M to C$4.6M. Net loss before extraordinary items decreased 13% to C$5.9M. Revenues reflect Health Technology segment increase from C$119K to C$712K. Lower net loss reflects Impairment of investment in an associate decrease from C$2.3M (expense) to C$0K, Research and development - Balancing v decrease of 52% to C$755K (expense). |
Employees: | 340 as of Dec 31, 2020 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $190.74M as of Mar 31, 2024 |
Annual revenue (TTM): | $9.92M as of Mar 31, 2024 |
EBITDA (TTM): | -$14.52M as of Mar 31, 2024 |
Net annual income (TTM): | -$31.34M as of Mar 31, 2024 |
Free cash flow (TTM): | -$17.13M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $14.77M as of Mar 31, 2024 |
Shares outstanding: | 145,480,688 as of May 13, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |